No Data
Lan Feng Biochemical: 2024 Annual Results Forecast
Jiangsu Lanfeng Bio-chemical (002513.SZ): Expected loss of 0.21 billion yuan to -0.29 billion yuan for the year 2024.
On January 20, Gelonghui reported that Jiangsu Lanfeng Bio-chemical (002513.SZ) announced its performance forecast for 2024, predicting a net income loss attributable to shareholders of the listed company of 0.29 billion yuan to 0.21 billion yuan, compared to a loss of 332.2604 million yuan in the same period last year; the net income loss after deducting non-recurring gains and losses is expected to be 0.27 billion yuan to 0.19 billion yuan, compared to a loss of 361.2976 million yuan in the same period last year; the basic EPS loss is expected to be 0.79 yuan per share to 0.57 yuan per share. During the reporting period, the company anticipates a net income loss attributable to shareholders of the listed company, mainly due to the company and its subsidiaries regarding various assets at the end of the reporting period.
Little Excitement Around Jiangsu Lanfeng Bio-chemical Co.,Ltd's (SZSE:002513) Revenues As Shares Take 25% Pounding
Jiangsu Lanfeng Bio-Chemical (002513.SZ): Xuhe Technology's TOPCon solar cells average mass production efficiency has reached 26.5%.
On November 18th, Jiangsu Lanfeng Bio-chemical (002513.SZ) stated on the investor interactive platform that its holding subsidiary, Xuhe Technology's TOPCon solar cells have achieved an average production efficiency of 26.5%. The highest power of efficient TOPCon modules can reach above 720W, with an efficiency of over 23.6%, and a bifacial rate exceeding 85%.
Lan Fung Biochemical: Report for the Third Quarter of 2024
Jiangsu Lanfeng Bio-Chemical (002513.SZ) released its performance for the first three quarters, with a net loss of 0.185 billion yuan.
Jiangsu Lanfeng Bio-chemical (002513.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue...
Revenues Not Telling The Story For Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) After Shares Rise 26%
